153 related articles for article (PubMed ID: 5060511)
1. Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.
Bowers MB
Neuropharmacology; 1972 Jan; 11(1):101-11. PubMed ID: 5060511
[No Abstract] [Full Text] [Related]
2. Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
Chase RN; Schnur JA; Brody JA; Gordon EK
Arch Neurol; 1971 Jul; 25(1):9-13. PubMed ID: 5146413
[No Abstract] [Full Text] [Related]
3. Cerebrospinal fluid probenecid studies: a reinterpretation.
Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
[TBL] [Abstract][Full Text] [Related]
4. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
[No Abstract] [Full Text] [Related]
5. Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid.
Cohen DJ; Caparulo BK; Shaywitz BA; Bowers MB
Arch Gen Psychiatry; 1977 May; 34(5):545-50. PubMed ID: 860891
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.
Goodwin FK; Post RM; Dunner DL; Gordon EK
Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466
[No Abstract] [Full Text] [Related]
7. Amyotrophic lateral sclerosis: metabolism of central monoamines and treatment with L-dopa.
Mendell JR; Chase TN; Engel WK
Trans Am Neurol Assoc; 1971; 96():284-6. PubMed ID: 5159109
[No Abstract] [Full Text] [Related]
8. Amine metabolism in the human brain: further evaluation of the probenecid test.
Korf J; Van Praag HM
Brain Res; 1971 Dec; 35(1):221-30. PubMed ID: 5134227
[No Abstract] [Full Text] [Related]
9. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
[No Abstract] [Full Text] [Related]
10. Deficient transport mechanism for the removal of acid monoamine metabolites from cerebrospinal fluid.
Bowers MB
Brain Res; 1969 Oct; 15(2):522-4. PubMed ID: 5344382
[No Abstract] [Full Text] [Related]
11. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system].
Campanella G; Orefice G; Carrieri P; Mandarini A; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):571-9. PubMed ID: 138341
[No Abstract] [Full Text] [Related]
12. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
[No Abstract] [Full Text] [Related]
13. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
Mendlewicz J; Vanderheyden JE; Noel G
Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
[TBL] [Abstract][Full Text] [Related]
14. Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid.
Korf J; van Praag HM; Sebens JB
Biochem Pharmacol; 1971 Mar; 20(3):659-68. PubMed ID: 5150161
[No Abstract] [Full Text] [Related]
15. Assessment of cerebrospinal monoamine metabolites in children using the probenecid method.
Cohen DJ; Caparulo BK; Shaywitz BA; Bowers MB
Isr Ann Psychiatr Relat Discip; 1977; 15(1):47-57. PubMed ID: 268307
[No Abstract] [Full Text] [Related]
16. Acid metabolites from monoamines in cerebrospinal fluid of chronic schizophrenics.
Persson T; Roos BE
Br J Psychiatry; 1969 Jan; 115(518):95-8. PubMed ID: 5781964
[No Abstract] [Full Text] [Related]
17. CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
Leckman JF; Cohen DJ; Shaywitz BA; Caparulo BK; Heninger GR; Bowers MB
Arch Gen Psychiatry; 1980 Jun; 37(6):677-81. PubMed ID: 6155891
[TBL] [Abstract][Full Text] [Related]
18. Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease).
Gottfires CG; Roos BE
Acta Psychiatr Scand; 1973; 49(3):257-63. PubMed ID: 4715071
[No Abstract] [Full Text] [Related]
19. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
Olsson R; Roos BE
Nature; 1968 Aug; 219(5153):502-3. PubMed ID: 5668438
[No Abstract] [Full Text] [Related]
20. Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patients.
Bridges PK; Bartlett JR; Sepping P; Kantamaneni BD; Curzon G
Psychol Med; 1976 Aug; 6(3):399-405. PubMed ID: 996200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
